Regarding Drilling Contract
September 15, 2005 02:00 ET
|
Wentworth Resources Plc
On September 6th, the Company entered into a contract with IROilRigs Int`l Ltd. of Hong Kong to supply a drilling rig for the required drilling program at Mnazi Bay, Tanzania. The American made Ideco...
Gamla Liv höjer återbäringsräntan till 5 procent
September 15, 2005 02:00 ET
|
SEB
Gamla Livförsäkringsaktiebolaget är ett av marknadens finansiellt starkaste bolag och finansavkastningen hittills under 2005 har varit god. I en samlad bedömning av aktuell konsolidering och...
UCB's Anti-Epilectic Keppra Meets Primary End-Point in Monotherapy Trial
September 15, 2005 01:53 ET
|
UCB
BRUSSELS, Belgium, Sept. 15, 2005 (PRIMEZONE) -- UCB today announced that the primary end-point from its pivotal Phase III monotherapy clinical trial had been met. This trial compared Keppra(R)...
L'ANTI-EPILEPTIQUE KEPPRA® D'UCB SATISFAIT AU CRITERE D'EVALUATION PRINCIPAL DANS UN ESSAI DE MONOTHERAPIE
September 15, 2005 01:45 ET
|
UCB
Bruxelles, Belgique, le 15 septembre 2005 : UCB a annoncé aujourd'hui que le critère d'évaluation principal de l'essai clinique de phase III en monothérapie a été satisfait. Cet essai déterminant...
UCB'S ANTI-EPILEPTICA KEPPRA® HAALT PRIMAIRE EINDPUNT IN MONOTHERAPIEONDERZOEK
September 15, 2005 01:45 ET
|
UCB
Brussel, BELGIË, 15 september 2005: UCB heeft vandaag aangekondigd dat het eindpunt van het klinische monotherapieonderzoek Fase III werd gehaald. Dit onderzoek vergeleek Keppra® (levetiracetam) met...
UCB'S ANTI-EPILECTIC KEPPRA® MEETS PRIMARY END-POINT IN MONOTHERAPY TRIAL
September 15, 2005 01:45 ET
|
UCB
Brussels, BELGIUM September 15th, 2005: UCB today announced that the primary end-point from its pivotal Phase III monotherapy clinical trial had been met. This trial compared Keppra®...
Novartis signs global licensing agreement to develop new topical applications of terbinafine the most prescribed oral treatment for fungal nail infections
September 15, 2005 01:30 ET
|
Novartis Pharma AG
Basel, September 15, 2005 - Novartis announced today that it has signed a global licensing agreement with NexMed, Inc (NASDAQ: NEXM) to develop new topical forms of terbinafine, the active ingredient...
Friendly Energy Update
September 14, 2005 23:40 ET
|
Friendly Energy Corporation
CARSON CITY, Nev., Sept. 14, 2005 (PRIMEZONE) -- Friendly Energy Corporation (Pink Sheets:FDEG) is pleased to announce that it has received commitments from certain institutional investors, subject...
Media Advisory -- Sept. 14 Northrop Grumman Update for Gulf Coast Employees
September 14, 2005 21:59 ET
|
Northrop Grumman Corporation
MEDIA ADVISORY, Sept. 14, 2005 (PRIMEZONE) --
Note to Editors and News Directors:
Northrop Grumman and its employees greatly appreciate your continued assistance in sharing these updates on your...
Photo Release -- Northrop Grumman Gulf Coast Employees Return to Work
September 14, 2005 21:39 ET
|
Northrop Grumman Corporation
PASCAGOULA, Miss., Sept. 14, 2005 (PRIMEZONE) -- Northrop Grumman Corporation (NYSE: NOC) today released a photo of employees at its Ship Systems sector returning to work.
This photo is available...
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
- July 26, 2024 16:30 ET Arhaus Unveils Showroom in Palo Alto, California